Clinical Trials at Beverly Hills Cancer Center
As of August 2026, 15 paid clinical trials are recruiting at Beverly Hills Cancer Center, located at 8900 WILSHIRE BLVD, BEVERLY HILLS, CA 90211-1958, phone (310) 740-7500 in Beverly Hills, California. Active studies at this site cover conditions such as Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer and Metastatic Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
15 clinical trials at Beverly Hills Cancer Center
·Clear filters·Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
Common conditions studied in Beverly Hills
- Anatomic Stage II Breast Cancer AJCC v8 (7 active studies)
- Breast Cancer (7 active studies)
- Metastatic Breast Cancer (5 active studies)
- Multiple Myeloma (5 active studies)
- Non Small Cell Lung Cancer (5 active studies)
- Systemic Lupus Erythematosus (5 active studies)
Leading research sponsors in Beverly Hills
- National Cancer Institute (NCI)
- AstraZeneca
- SWOG Cancer Research Network
- NRG Oncology
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Beverly Hills?
There are approximately 169 recruiting clinical trials in Beverly Hills, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Beverly Hills pay participants?
Most recruiting trials in Beverly Hills compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Beverly Hills?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Beverly Hills?
The most common conditions under active study in Beverly Hills include Anatomic Stage II Breast Cancer AJCC v8 (7), Breast Cancer (7), Metastatic Breast Cancer (5), Multiple Myeloma (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Beverly Hills?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Beverly Hills on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Beverly Hills?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Beverly Hills?
Recruiting research sites in Beverly Hills include Tower Cancer Research Foundation, Beverly Hills Cancer Center, National Heart Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Beverly Hills right now?
The largest active categories in Beverly Hills are Cancer & tumors (78), Cardiovascular (13), Eye & vision (13). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Beverly Hills Cancer Center?
Beverly Hills Cancer Center is located at 8900 WILSHIRE BLVD, BEVERLY HILLS, CA 90211-1958. Use the Google Maps link in the intro above to get directions.
How do I contact Beverly Hills Cancer Center?
You can reach Beverly Hills Cancer Center by phone at (310) 740-7500. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.